Meitav Trade: How Much of the Cash Is Actually Accessible to Shareholders
The main article already flagged that a large share of Meitav Trade's reported liquidity is not truly free. This follow-up breaks down the number: out of ILS 174.6 million of balance-sheet liquidity, ILS 72.4 million sits in trust-account surpluses and another ILS 81.7 million is pledged or regulatory, so the real question is not how much cash is reported, but how much can actually reach shareholders.
What This Follow-up Is Isolating
The main article already made the core point: with Meitav Trade, it is not enough to look at client growth or at net income. The real question is how much of that profit becomes a resource that is actually available to shareholders. This follow-up isolates only the cash layer: what inside reported liquidity is really client or regulatory cash, what sits inside the operating subsidiary as capital notes, and what remains at the layer that could even begin to be treated as shareholder-accessible cash.
The sharp read is this:
- ILS 174.6 million of headline liquidity is not ILS 174.6 million of free cash. At year-end 2025 the company reported ILS 92.3 million of cash and cash equivalents and another ILS 82.3 million of deposits, pledged cash and securities. But ILS 72.4 million of the cash line was trust-account surplus cash, ILS 49.9 million was held for the TASE clearing-house risk fund, and another ILS 31.8 million was pledged for derivatives activity.
- Even what remains after stripping those layers is not a shareholder cash box. If you deduct the trust surplus and the two collateral buckets from reported liquidity, roughly ILS 20.5 million remains, just under 12% of the headline number. That is an analytical bridge, not a disclosed “free cash” line, and it comes before taking account of the client-credit book and the day-to-day capital needs of the business.
- A large part of the capital already pushed into the operating layer sits as capital notes, not as distributable cash. At the reporting date Meitav Trade had ILS 61.2 million of capital notes outstanding, of which ILS 58.2 million was owed to the listed company and ILS 3 million to the ultimate parent. The notes owed to the listed company are non-interest-bearing, non-linked, and can be repaid early only at Meitav Trade’s discretion.
That chart is the core of the follow-up. This is not an accounting error. It is simply brokerage economics. The question is whether the reader treats the balance-sheet number as cash sitting idle, or understands that most of it is already spoken for inside the operating and regulatory machinery.
Peeling Back the Liquidity Layer
The right cash framing here is all-in cash flexibility. The relevant question is not how much cash the business might produce in a cleaner theoretical setup. The relevant question is how much room is left after the clearing-house, collateral and real operating uses of cash are taken into account.
The cash note already reveals the first part of the gap. Out of ILS 92.3 million of cash and cash equivalents, ILS 72.4 million was defined as surplus cash in trust accounts. That is not a footnote. At the same time, the company holds securities and cash in trust for clients, directly or through banks and other institutions, with a total value of ILS 41.351 billion. In that context, the trust-account surplus is not cash sitting above the business. It is part of the infrastructure inside which the business operates.
The note on designated and pledged deposits leaves very little room for wishful thinking as well. Out of ILS 82.3 million of deposits, pledged cash and securities, ILS 31.8 million served as collateral to a bank that is a member of the derivatives clearing system, and ILS 49.9 million was deposited for the TASE clearing-house risk fund. In plain English, almost the entire line already has a purpose attached to it.
The working-capital and financing sections reinforce the same point. The company states that most custodian-client credit is repaid within up to two days, and that Meitav Trade receives credit from various parties for that purpose. So part of what looks like liquidity on the balance sheet is really part of the settlement engine, not excess capital waiting to be distributed.
| Layer | Amount | What It Means Economically |
|---|---|---|
| Cash and cash equivalents | ILS 92.3 million | The first headline number |
| Of which trust-account surplus | ILS 72.4 million | Cash embedded in the trust-account infrastructure |
| Deposits, pledged cash and securities | ILS 82.3 million | The second headline number |
| Derivatives collateral | ILS 31.8 million | Operating collateral posted to a bank |
| Risk-fund deposit | ILS 49.9 million | Regulatory collateral for the clearing house |
| Client credit | ILS 85.2 million | Balance-sheet usage that supports activity, not distributions |
| Liability to broker for client credit | ILS 19.6 million | The matching leg for part of the FX client-credit activity |
| Residual after stripping trust and collateral | About ILS 20.5 million | An analytical bridge, not a disclosed free-cash line |
That table also explains why the roughly ILS 20.5 million figure has to be handled carefully. It says the gap between reported liquidity and clean liquidity is large. It does not say that ILS 20.5 million is sitting there for shareholders. The business still carries ILS 85.2 million of client credit, including ILS 19.5 million of FX credit extended through Interactive Brokers and recognized against a broker liability in payables. So even the non-pledged residual still has to support the operating model before it can become a candidate for distributions.
What Actually Reaches Shareholders
This is the layer that is easiest to miss if you only look at the consolidated balance sheet. Even when the value economically belongs to shareholders, it does not always sit in a form that can be upstreamed immediately.
The clearest example is the capital-note structure. At the end of 2025, Meitav Trade had ILS 61.2 million of capital notes outstanding, of which ILS 58.2 million was owed to the listed company. Those notes are meant to count as primary regulatory capital for TASE purposes. They bear no interest or indexation, and early repayment is at Meitav Trade’s sole discretion. Economically, that is value that belongs to the listed company. Practically, it is value sitting inside the operating subsidiary, and the subsidiary decides when and whether it can be released.
That decision is not made in a vacuum. As of December 31, 2025, Meitav Trade’s required equity stood at about ILS 133 million, of which roughly ILS 113 million was primary equity. In addition, it was required to hold about ILS 227 million of net free liquid assets. Once those numbers are on the table, it becomes clear why the capital notes are not the same thing as an open cash balance.
The financing section points in the same direction. The company’s credit lines are not lines that can simply be “taken home.” There is a ILS 60 million line for derivatives activity, a non-binding ILS 160 million on-call facility for client credit, a ILS 45 million short-sale line, and a ILS 91.3 million RTGS daily settlement line. No on-call loans were drawn at year-end, but the entire framework is built around pledged deposits or securities, and the bank can accelerate the facilities if collateral requirements are not met. This is an operating pipe, not a substitute for shareholder-accessible cash.
There is, of course, a shareholder layer that did receive cash in practice. During 2025 the company declared and paid aggregate dividends of ILS 46.8 million, and after the balance-sheet date it approved another ILS 13.9 million dividend. At March 16, 2026, it also had ILS 38.2 million of distributable profits at the company level. That proves cash can move upstream. But it does not weaken the thesis here. It sharpens it: the cash that reaches shareholders is what remains after capital requirements, liquidity requirements, collateral, client-credit support and capital reallocation back into the operating subsidiary.
The sequence of post-balance-sheet events shows how actively that margin is managed. In January and February 2026, the clearing house updated Meitav Trade’s share in the risk fund to ILS 57.8 million and then ILS 54.9 million. On January 15, 2026, ILS 3 million of interest-bearing capital notes owed to Meitav Investment House were repaid. On January 14 and February 22, 2026, Meitav Trade issued two additional ILS 1 million capital notes to the listed company. This is not a picture of idle excess cash. It is a picture of capital constantly moving between the shareholder layer and the regulatory needs of the brokerage operation.
Bottom Line
The easy mistake in reading Meitav Trade is to see ILS 174.6 million of balance-sheet liquidity and assume there is a wide cash cushion for shareholders. That is the wrong read. The number includes trust-account surplus cash, designated deposits, regulatory collateral and credit infrastructure without which the business cannot operate.
The more accurate read is this: the business does generate cash, and in 2025 it even generated a strong ILS 90.6 million of operating cash flow. But that cash first has to pass through the client engine, the clearing system, the collateral stack and the regulatory-capital layer. Only what survives those layers can become a dividend, and sometimes even that gets recycled back into the operating subsidiary as a new capital note.
That is why the gap between reported cash and shareholder-accessible cash is not a cosmetic accounting issue. It is a core part of Meitav Trade’s economics as a listed brokerage company. Anyone trying to judge the quality of value here should watch not just net income, but three much less glamorous figures: the size of trust-account surplus cash, the size of regulatory deposits and collateral, and the direction of capital notes between the listed company and Meitav Trade.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.